慢性乙型肝炎抗病毒治疗期间肝内共价闭合环状DNA和血清乙型肝炎表面抗原的动力学：来自实验和临床研究的经验教训 - Suppr

Suppr

超能文献

Kinetics of intrahepatic covalently closed circular DNA and serum hepatitis B surface antigen during antiviral therapy for chronic hepatitis B: lessons from experimental and clinical studies.

作者信息

Zoulim Fabien, Testoni Barbara, Lebossé Fanny

出版信息

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1011-3. doi: 10.1016/j.cgh.2013.04.010. Epub 2013 Apr 16.

DOI:10.1016/j.cgh.2013.04.010

PMID:23602824

Abstract

摘要

相似文献

Kinetics of intrahepatic covalently closed circular DNA and serum hepatitis B surface antigen during antiviral therapy for chronic hepatitis B: lessons from experimental and clinical studies.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1011-3. doi: 10.1016/j.cgh.2013.04.010. Epub 2013 Apr 16.

Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1004-10.e1. doi: 10.1016/j.cgh.2013.01.026. Epub 2013 Feb 1.

Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?

J Clin Microbiol. 2017 Oct;55(10):2972-2982. doi: 10.1128/JCM.00760-17. Epub 2017 Jul 26.

Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.

Antivir Ther. 2008;13(1):57-66.

[One case of newly-onset liver cancer and dual drug-resistance during treatment of hepatitis B cirrhosis with nucleos(t)ide analogues].

Zhonghua Gan Zang Bing Za Zhi. 2016 Mar 20;24(3):228-9. doi: 10.3760/cma.j.issn.1007-3418.2016.03.014.

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

Clin Gastroenterol Hepatol. 2007 Dec;5(12):1462-8. doi: 10.1016/j.cgh.2007.09.005.

Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B.

PLoS One. 2015 Feb 3;10(2):e0117741. doi: 10.1371/journal.pone.0117741. eCollection 2015.

Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

Clin Gastroenterol Hepatol. 2007 Aug;5(8):890-7. doi: 10.1016/j.cgh.2007.05.004. Epub 2007 Jul 13.

Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.

Liver Transpl. 2016 Sep;22(9):1205-13. doi: 10.1002/lt.24493. Epub 2016 Aug 1.

Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.

J Gastroenterol Hepatol. 2011 Oct;26(10):1527-35. doi: 10.1111/j.1440-1746.2011.06766.x.

引用本文的文献

Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B.

Viruses. 2024 Mar 29;16(4):529. doi: 10.3390/v16040529.

Past, present, and future of long-term treatment for hepatitis B virus.

World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.

Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e AntigenNegative Chronic Hepatitis B Patients.

Turk J Gastroenterol. 2023 Apr;34(4):378-382. doi: 10.5152/tjg.2020.19612.

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B.

Gut Liver. 2023 Mar 15;17(2):280-287. doi: 10.5009/gnl220122. Epub 2022 Nov 1.

Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus.

Hepat Med. 2022 Jul 29;14:87-100. doi: 10.2147/HMER.S291976. eCollection 2022.

Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery.

Innovation (Camb). 2020 Aug 5;1(2):100034. doi: 10.1016/j.xinn.2020.100034. eCollection 2020 Aug 28.

Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B.

Viruses. 2021 Apr 9;13(4):648. doi: 10.3390/v13040648.

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.

Genes (Basel). 2019 Apr 1;10(4):260. doi: 10.3390/genes10040260.

Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patients.

Cell Biosci. 2018 Feb 20;8:14. doi: 10.1186/s13578-018-0215-5. eCollection 2018.

Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs.

Sci Rep. 2017 Oct 17;7(1):13383. doi: 10.1038/s41598-017-13747-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验